US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 20.5300
  • -2.2800-10.00%
Close Dec 18 16:00 ET
  • 19.5800
  • -0.9500-4.63%
Pre 04:33 ET
224.58MMarket Cap-0.89P/E (TTM)

About Cidara Therapeutics Company

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolCDTX
Company NameCidara Therapeutics
Listing DateApr 15, 2015
Issue Price16.00
Founded2012
CEODr. Jeffrey Stein, PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address6310 Nancy Ridge Drive,Suite 101
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-752-6170

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeffrey Stein, PhD
  • Director, President and Chief Executive Officer
  • 1.56M
  • Leslie Tari
  • Chief Scientific Officer
  • --
  • Shane M. Ward
  • Chief Operating Officer, Chief Legal Officer and Corporate Secretary
  • 929.86K
  • Dr. Taylor Sandison, M.D.
  • Chief Medical Officer
  • 884.09K
  • Dr. Preetam Shah, M.B.A.,PhD
  • Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
  • --
  • Daniel D. Burgess
  • Chairman of the Board
  • 126.84K
  • Dr. James Merson, PhD
  • Director
  • --
  • Dr. Laura Tadvalkar, PhD
  • Director
  • --
  • Ryan Spencer
  • Director
  • --
  • Dr. Bonnie L. Bassler, PhD
  • Independent Director
  • 86.84K
  • Chrysa Mineo
  • Independent Director
  • 91.34K
  • Carin Canale-Theakston
  • Independent Director
  • 82.34K
  • Theodore R. Schroeder
  • Independent Director
  • 98.84K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.